Who builds this, and why it reads differently

It changes what an explanation is for. A typical answer key says which option is correct. Here the aim is to tell you which provision decides it — the section, rule or schedule — so that you can go and read the source yourself and remember the principle rather than the option letter.

It also changes emphasis. Topic weightage on this site is measured from actual previous papers rather than guessed, so the plan follows where the marks genuinely are. You can see the method on the methodology page.

This portal has no connection to the conduct of any examination. It is not affiliated with, endorsed by, or associated with UPSC, CDSCO or NBEMS. It carries no inside knowledge of any paper, no leaked material, and no influence over selection. The value on offer is subject expertise and the discipline of citing sources — nothing else, and nothing closer than that.

If the author ever becomes associated with a recruitment or selection process for an examination this portal serves, any paid feature for that examination would be paused for that cycle. Everything is free today, so the rule costs nothing to state now — and stating it now is the point.

Questions are drafted from primary sources — the Drugs and Cosmetics Act 1940 and Rules 1945, MDR 2017, NDCT Rules 2019, Cosmetics Rules 2020, DPCO 2013, the Pharmacy Act 1948 — and from the prescribed B.Pharm syllabus for GPAT. Drafting is assisted by AI and every item is then independently fact-checked by a second model before it can be served.

That process is good, and it is not the same as expert review. So rather than make one blanket claim, every question carries its own status next to its explanation: source cited, AI fact-checked, or awaiting expert review. Where a question is uncertain, it says so and tells you to trust your textbook.

Every question also has a one-tap report control. Reports go to a review queue and are acted on. If you find something wrong, that is genuinely useful — please send it.

Everything is free: the full question bank, mock tests, explanations and analytics. There is no paywall, no trial expiry and no card on file. The bank is worth more to more people than it is worth as revenue at this stage.

Corrections, questions and suggestions: anil.dca.1@gmail.com. For anything about your personal data, see the privacy page.